Top

Published in:

Open Access 01-12-2012 | Editorial

Translational medicine as a permanent glue and force of clinical medicine and public health: perspectives (1) from 2012 Sino-American symposium on clinical and translational medicine

Authors: Jiebai Zhou, Duojiao Wu, Xinqing Liu, Shuoqi Yuan, Xiaoqiu Yang, Xiangdong Wang

Published in: Clinical and Translational Medicine | Issue 1/2012

Abstracts

Health systems globally face challenges and opportunities in balancing quality, access, and cost, where clinical and translational medicine (CTM) should play more important and powerful roles in the identification, development and validation of solutions and strategies. Strategic collaboration can gather global strengths and resources and improve health systems, care delivery, regulations and policies. CTM-driven innovation and development has the potential to achieve step-change improvements across three dimensions. Thus, we have the reasons to believe that CTM will play even more roles in the development of new diagnostics, therapies, healthcare, and policies and SAS-CTM will become more and more important platform to obtain the latest development in CTM internationally and explore new opportunities in the international collaborations.

Available only for authorised users

Zerhouni E: Medicine. The NIH Roadmap. Science 2003, 302: 63–72. 10.1126/science.1091867CrossRefPubMed

Marincola FM: Translational medicine: a two way road. J Transl Med 2003, 1: 1. 10.1186/1479-5876-1-1PubMedCentralCrossRefPubMed

Abraham E, Marincola FM, Chen ZN, Wang XD: Clinical and translational medicine: Integrative and practical science. Clinical and Translational Medicine 2012, 1: 1. 10.1186/2001-1326-1-1PubMedCentralCrossRefPubMed

Waldman SA, Terzic A: Clinical and translational science: from bench-bedside to global village. Clin Transl Sci 2010, 3: 254–257. 10.1111/j.1752-8062.2010.00227.xCrossRefPubMed

Littman BH, Di Mario L, Plebani M, Marincola FM: What’s next in Translational Medicine? Clin Sci (Lond) 2007, 112: 217–227. 10.1042/CS20060108CrossRef

Wang XD, Wang E, Marincola FM: Translational medicine is developing in China: a new venue for collaboration. J Transl Med 2011, 9: 3. 10.1186/1479-5876-9-3PubMedCentralCrossRefPubMed

Collins FS: Research agenda. Opportunities for research and NIH. Science 2010, 327: 36–37. 10.1126/science.1185055CrossRefPubMed

Scannell JW, Blanckley A, Boldon H, Warrington B: Diagnosing the decline in pharmaceutical R&D efficiency. Nat Rev Drug Discov 2012, 11: 191–200. 10.1038/nrd3681CrossRefPubMed

Kola I, Landis J: Can the pharmaceutical industry reduce attrition rates? Nat Rev Drug Discov 2004, 3: 711–715. 10.1038/nrd1470CrossRefPubMed

10.

Day M, Rutkowski JL, Feuerstein GZ: Translational medicine–a paradigm shift in modern drug discovery and development: the role of biomarkers. Adv Exp Med Biol 2009, 655: 1–12. 10.1007/978-1-4419-1132-2_1CrossRefPubMed

11.

Wu X, Chen H, Wang XD: Can lung cancer stem cells be targeted for therapies? Cancer Treat Rev 2012, 38: 580–588. 10.1016/j.ctrv.2012.02.013CrossRefPubMed

12.

Wang X: Role of clinical bioinformatics in the development of network-based biomarkers. J Clin Bioinforma 2011, 1: 28. 10.1186/2043-9113-1-28PubMedCentralCrossRefPubMed

13.

Lee IH, Lushington GH, Visvanathan M: A filter-based feature selection approach for identifying potential biomarkers for lung cancer. J Clin Bioinforma 2011, 1: 11. 10.1186/2043-9113-1-11PubMedCentralCrossRefPubMed

14.

Trovato GM: Behavior, nutrition and lifestyle in a comprehensive health and disease paradigm: skills and knowledge for a predictive, preventive and personalized medicine. EPMA J 2012, 3: 8.PubMedCentralCrossRefPubMed

15.

Tricoci P, Allen JM, Kramer JM, Califf RM, Smith SC Jr: Scientific evidence underlying the ACC/AHA clinical practice guidelines. JAMA 2009, 301: 831–841. 10.1001/jama.2009.205CrossRefPubMed

16.

Califf RM, Zarin DA, Kramer JM, Sherman RE, Aberle LH, Tasneem A: Characteristics of clinical trials registered in ClinicalTrials.gov, 2007–2010. JAMA 2012, 307: 1838–1847. 10.1001/jama.2012.3424CrossRefPubMed

17.

Dzau VJ, Ackerly DC, Sutton-Wallace P, Merson MH, Williams RS, Krishnan KR, Taber RC, Califf RM: The role of academic health science systems in the transformation of medicine. Lancet 2010, 375: 949–953. 10.1016/S0140-6736(09)61082-5CrossRefPubMed

Title: Translational medicine as a permanent glue and force of clinical medicine and public health: perspectives (1) from 2012 Sino-American symposium on clinical and translational medicine
Authors: Jiebai Zhou
Duojiao Wu
Xinqing Liu
Shuoqi Yuan
Xiaoqiu Yang
Xiangdong Wang
Publication date: 01-12-2012
Publisher: Springer Berlin Heidelberg
Published in: Clinical and Translational Medicine / Issue 1/2012
Electronic ISSN: 2001-1326
DOI: https://doi.org/10.1186/2001-1326-1-21

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Translational medicine as a permanent glue and force of clinical medicine and public health: perspectives (1) from 2012 Sino-American symposium on clinical and translational medicine

Abstracts

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstracts

Please log in to get access to this content

Other articles of this Issue 1/2012

Clinical and translational medicine: Integrative and practical science.

Towards a “4I” approach to personalized healthcare

Dose-dependent Effect of Statin Therapy on Circulating CXCL12 Levels in Patients with Hyperlipidemia

Bioinformatics insights into acute lung injury/acute respiratory distress syndrome

Therapeutic potential of targeting IL-17 and IL-23 in sepsis

Relevant phosphoproteomic and mass spectrometry: approaches useful in clinical research